Larchmont, NY, United States of America

Matthew D Scharff

This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignee: Albert Einstein College of Medicine. Active years: 1999-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthew D Scharff. Retrieved from https://idiyas.com/inventor/matthew-d-scharff

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 75.0

Average Co-Inventor Count = 3.2

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1999-2019

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Matthew D. Scharff: A Look into His Contributions to Immunology

Introduction

Matthew D. Scharff is an accomplished inventor based in Larchmont, NY, recognized for his significant contributions to the field of immunology. With a total of four patents to his name, Scharff has made strides in developing methods and peptides that advance our understanding and treatment of autoimmune diseases.

Latest Patents

Among his innovative contributions, two of Scharff's latest patents stand out. The first is titled "Methods to accelerate antibody diversification - Methods for increasing somatic hypermutation of antibodies." This invention presents techniques for enhancing the diversification of antibodies, particularly through the in vitro expression of isolated retroviral proteins in mammalian immunoglobulin-producing cells.

The second patent, "Peptides for detecting anti-double stranded DNA antibody and uses thereof," provides a method for identifying peptides that bind to anti-double stranded DNA antibodies. This invention includes a class of peptides that can specifically bind to these antibodies, paving the way for novel diagnostic and therapeutic approaches for systemic lupus erythematosus.

Career Highlights

Matthew D. Scharff is affiliated with the Albert Einstein College of Medicine, where he actively engages in research and innovation. His work is integral to advancing scientific knowledge, significantly impacting the medical field, particularly in autoimmune research.

Collaborations

Throughout his career, Scharff has collaborated with notable colleagues such as Bruce D. Gaynor and Betty A. Diamond. These partnerships have facilitated groundbreaking research, resulting in important advancements in understanding immune responses and developing related treatments.

Conclusion

In conclusion, Matthew D. Scharff's contributions to immunology through his patents and collaborative efforts exemplify the spirit of innovation in the medical field. His work continues to inspire and lead the way in developing new diagnostic and therapeutic tools that hold promise for treating complex autoimmune diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…